HealthTree Logo
search more_vert
App Logo
person Sign In / Create Account
Exploring the Selinexor STOMP Trial
Exploring the Selinexor STOMP Trial  image
Selinexor Treatment Information Chapter
event Apr 05, 2022 / 07:00PM - 08:00PM EDT

Event Description

Join Dr. Chakraborty to learn about the Selinexor STOMP Trial and get answers to your questions like:

  1. Why test selinexor with so many different myeloma treatments aka why so many arms?
  2. What are we looking to discover and how soon could we get results?
  3. How can patients enroll in the trial, who qualifies for the clinical trials, and why should they join?

Schedule & Agenda

Audrey Burton-Bethke
Audrey introduces the agenda of the event and featured speaker Dr. Rajshekhar Chakraborty.
Dr. Rajshekhar Chakraborty
Dr. Rajshekhar Chakraborty talks about Selinexor and the results we can see in clinical trials.
Group Discussion
Type your questions in the chat and we will answer them!

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Dr. Rajshekhar Chakraborty
Dr. Rajshekhar Chakraborty

Rajshekhar Chakraborty, MD is an assistant professor of medicine at Columbia University Irving Medical Center in the division of hematology/oncology. After receiving his medical degree from University of Delhi, India, he completed his residency in internal medicine at Icahn School of Medicine at Mount Sinai-Queens Hospital Center. Subsequently, he spent three years as a clinical researcher in plasma cell disorders at the Mayo Clinic, Rochester, followed by fellowship in hematology/oncology at the Cleveland Clinic. Dr. Chakraborty cares primarily for patients with plasma cells disorders, including multiple myeloma, amyloidosis, MGUS, POEMS syndrome, and Waldenstrom's macroglobulinemia. His research interests include clinical trials and outcomes research in plasma cell disorders.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.


Get In Touch With Us


+1 800 709 1113


Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Janssen Oncology
Adaptive Biotechnologies
Amgen Oncology
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube